Influence of pharmacokinetic model of propofol on the predicted plasma concentration

Influence of pharmacokinetic model of propofol on the predicted plasma concentration - Influence of pharmacokinetic model of propofol on the predicted plasma concentration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011754

Enrollment

Registered

2013-09-13

Start date

2013-09-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing elective surgery under general anesthesia

Interventions

propofol infusion at the maximum rate of 1200 ml/h using the Marsh pharmacokinetic model propofol infusion at the maximum rate of 300 ml/h using the Marsh pharmacokinetic model propofol infusion at

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients undergoing elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: significant heart, respiratory, hepatic, or renal imparement cardiovascular disease; recent use of psychoactive medicine; body mass index greater than 30

Design outcomes

Primary

Measure	Time frame
plasma concentration of propofol	—

Countries

Japan

Contacts

Public ContactKenichi Masui

National Defense Medical College Hospital Department of Anesthesiology

kenichi@masuinet.com04-2995-1692

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026